Citations

Showing 10 of 108094 citations.

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
Claxton, J’Neka S. , MacLehose, Richard F. , Chen, Lin Y. , Bengtson, Lindsay G.S. , Chamberlain, Alanna M. , Norby, Faye L. , Lutsey, Pamela L. , Chamberlain, Alanna M , Chen, Lin Y , Lutsey, Pamela L , O’Neal, Wesley T. , Sandesara, Pratik B. , Alonso, Álvaro

Mayo Clinic

Journal of the American Heart Association | March 11, 2018 | Volume: 7 | Issue: 6 | Pages: No page available

10.1161/jaha.117.007943 | PMID 29525778 Get It

Background Differences in anticoagulation rates and direct oral anticoagulant use by provider specialty may identify an area of practice improvement to reduce future stroke events in patients with atrial fibrillation ( AF ). Methods and Results We examined anticoagulant prescription fills in 388 045 (mean age, 68±15 years; 59% male) patients with incident AF from the MarketScan databases between 2009 and 2014. Provider specialty and filled anticoagulant prescriptions around the time of AF diagnosis (3 months before through 6 months after) were obtained from outpatient services and pharmacy claims. We estimated the association of provider specialty (cardiology versus primary care) with filling oral anticoagulant prescriptions, adjusting for patient characteristics. The risk of stroke and bleeding events also was explored. A total of 235 739 patients (61%) had a cardiology provider claim, whereas 152 306 (39%) were exclusively managed by primary care. Patients seen by cardiology providers were more likely to fill anticoagulant prescriptions than those seen by primary care (39% versus 27%; relative risk, 1.39; 95% confidence interval [ CI ], 1.37–1.40). Differences were observed for direct oral anticoagulants (relative risk, 1.74; 95% CI , 1.71–1.78) and warfarin (relative risk, 1.24; 95% CI , 1.22–1.26). A reduced risk of stroke events was observed among those seen by cardiology providers (hazard ratio, 0.90; 95% CI , 0.86–0.94) compared with primary care, without an increased bleeding risk (hazard ratio, 1.03; 95% CI , 0.98–1.07). Conclusions Patients seen by an outpatient cardiology provider shortly after AF diagnosis were more likely to initiate oral anticoagulation and were at lower risk of future stroke events without a higher rate of bleeding. Early referral to cardiology specialists may increase initiation of anticoagulant therapies and improve outcomes in AF .
Non–ST‐Segment–Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score–Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management
Bhatia, Subir , Arora, Shilpkumar , Bhatia, Subir , Al‐Hijji, Mohammed , Reddy, Yogesh N.V. , Patel, Parshva , Rihal, Charanjit S. , Deshmukh, Abhishek , Al-Hijji, Mohammed A , Nishimura, Rick , Rihal, Charanjit S. , Gersh, Bernard J.

Mayo Clinic

Journal of the American Heart Association | March 11, 2018 | Volume: 7 | Issue: 6 | Pages: No page available

10.1161/jaha.117.007920 | PMID 29525779 Get It

Background Chronic kidney disease ( CKD ) remains an independent predictor of cardiovascular morbidity and mortality. CKD complicates referral for percutaneous coronary intervention ( PCI ) in non–ST‐segment–elevation myocardial infarction ( NSTEMI ) patients because of the risk for acute kidney injury and the need for dialysis, with American College of Cardiology/American Heart Association guidelines underscoring the limited data on these patients. Methods and Results Using the National Inpatient Sample to analyze hospitalizations in the United States from 2004 to 2014, we sought to assess PCI utilization and in‐hospital outcomes in NSTEMI admissions with CKD . NSTEMI admissions were identified by International Classification of Diseases, Ninth Edition, Clinical Modification (ICD‐9‐CM) code 410.7. CKD admissions were identified by ICD‐9‐CM code 585. Propensity score–matched cohorts of patients with NSTEMI were matched for age, sex, comorbidities, race, median household income, primary payer status, and hospital characteristics. Of 4 488 795 hospitalizations for NSTEMI , 31% underwent PCI . Overall, 89% of admissions had no CKD . In addition, 32% of NSTEMI admissions with no CKD and 23%, 14%, and 22% with CKD stages 3, 4, and 5 underwent PCI , respectively. Hospitalized NSTEMI patients with CKD stages 4 and 5 had 41% and 20% less likelihood, respectively, of undergoing PCI compared with those with no CKD . Among hospitalized NSTEMI patients with no CKD or CKD stage 3, 4, or 5, PCI ‐treated groups had 63%, 57%, 39%, and 59% lower likelihood, respectively, of all‐cause, in‐hospital mortality compared with propensity score–matched medically managed groups. Conclusions PCI use decreased among hospitalized NSTEMI patients as CKD severity increased, and all‐cause, in‐hospital mortality was greater for NSTEMI patients admitted with more severe CKD regardless of treatment strategy.
Predictive Value of the Sequential Organ Failure Assessment Score for Mortality in a Contemporary Cardiac Intensive Care Unit Population
Bennett, Courtney , Wiley, Brandon M. , Murphree, Dennis H. , Keegan, Mark T. , Wright, R. Scott , Barsness, Gregory W. , Jentzer, Jacob C. , Gajic, Ognjen

Mayo Clinic

Journal of the American Heart Association | March 10, 2018 | Volume: 7 | Issue: 6 | Pages: No page available

10.1161/jaha.117.008169 | PMID 29525785 Get It

Background Optimal methods of mortality risk stratification in patients in the cardiac intensive care unit ( CICU ) remain uncertain. We evaluated the ability of the Sequential Organ Failure Assessment ( SOFA ) score to predict mortality in a large cohort of unselected patients in the CICU. Methods and Results Adult patients admitted to the CICU from January 1, 2007, to December 31, 2015, at a single tertiary care hospital were retrospectively reviewed. SOFA scores were calculated daily, and Acute Physiology and Chronic Health Evaluation ( APACHE )‐ III and APACHE ‐ IV scores were calculated on CICU day 1. Discrimination of hospital mortality was assessed using area under the receiver‐operator characteristic curve values. We included 9961 patients, with a mean age of 67.5±15.2 years; all‐cause hospital mortality was 9.0%. Day 1 SOFA score predicted hospital mortality, with an area under the receiver‐operator characteristic curve value of 0.83; area under the receiver‐operator characteristic curve values were similar for the APACHE ‐ III score, and APACHE ‐ IV predicted mortality ( P >0.05). Mean and maximum SOFA scores over multiple CICU days had greater discrimination for hospital mortality ( P <0.01). Patients with an increasing SOFA score from day 1 and day 2 had higher mortality. Patients with day 1 SOFA score <2 were at low risk of mortality. Increasing tertiles of day 1 SOFA score predicted higher long‐term mortality ( P <0.001 by log‐rank test). Conclusions The day 1 SOFA score has good discrimination for short‐term mortality in unselected patients in the CICU, which is comparable to APACHE ‐ III and APACHE ‐ IV . Advantages of the SOFA score over APACHE include simplicity, improved discrimination using serial scores, and prediction of long‐term mortality.
Vulvar neoplasms in 275 women with genital lichen sclerosus and impact of treatment: a retrospective chart review
Dell, E.A., Miest, Rachel Y. , Lohse, Christine M. , Torgerson, Rochelle R.

Mayo Clinic

Journal of the European Academy of Dermatology and Venereology | March 10, 2018 | Volume: 32 | Issue: 9 | Pages: No page available

10.1111/jdv.14938 | PMID 29524285 Get It

Erythromelalgia: improvement in pain with transcranial magnetic stimulation
Tjahjono, Leonardo , Sandroni, Paola , Sampson, Shirlene , Davis, Mark D. P. , Tjahjono, Leonardo A, Tjahjono, L A , Davis, Mark D.P.

Mayo Clinic

International Journal of Dermatology | March 10, 2018 | Volume: 58 | Issue: 1 | Pages: 101-102

10.1111/ijd.13963 | PMID 29524220 Get It

Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients
McDonough, Caitrin W. , Alghamdi, Wael A. , Arwood, Meghan J. , Bargal, Salma A. , Dumeny, Leanne , Mehanna, Mai , Stockard, Bradley , Yang, Guang , Oliveira, Felipe A. de, Fredette, Natalie C., Shahin, Mohamed H. , Bailey, Kent R. , Beitelshees, Amber L. , Boerwinkle, Eric , Chapman, Arlene B. , Gums, John G. , Johnson, Julie A. , Beitelshees, Amber L. , Turner, Stephen T. , Singh, Sonal , Gong, Yan , Li, Wenyi , Chapman, Arlene B. , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

Journal of the American Heart Association | March 10, 2018 | Volume: 7 | Issue: 6 | Pages: No page available

10.1161/jaha.117.007339 | PMID 29523524 Get It

Background Thiazide and thiazide‐like diuretics are first‐line medications for treating uncomplicated hypertension. However, their use has been associated with adverse metabolic events, including hyperglycemia and incident diabetes mellitus, with incompletely understood mechanisms. Our goal was to identify genomic variants associated with thiazide‐like diuretic/chlorthalidone‐induced glucose change. Methods and Results Genome‐wide analysis of glucose change after treatment with chlorthalidone was performed by race among the white (n=175) and black (n=135) participants from the PEAR ‐2 (Pharmacogenomic Evaluation of Antihypertensive Responses‐2). Single‐nucleotide polymorphisms with P <5×10 −8 were further prioritized using in silico analysis based on their expression quantitative trait loci function. Among blacks, an intronic single‐nucleotide polymorphism (rs9943291) in the HMGCS 2 was associated with increase in glucose levels following chlorthalidone treatment (ß=12.5; P =4.17×10 −8 ). G‐allele carriers of HMGCS 2 had higher glucose levels (glucose change=+16.29 mg/dL) post chlorthalidone treatment compared with noncarriers of G allele (glucose change=+2.80 mg/dL). This association was successfully replicated in an independent replication cohort of hydrochlorothiazide‐treated participants from the PEAR study (ß=5.54; P =0.023). A meta‐analysis of the 2 studies was performed by race in Meta‐Analysis Helper, where this single‐nucleotide polymorphism, rs9943291, was genome‐wide significant with a meta‐analysis P value of 3.71×10 −8 . HMGCS 2 , a part of the HMG ‐CoA synthase family, is important for ketogenesis and cholesterol synthesis pathways that are essential in glucose homeostasis. Conclusions These results suggest that HMGCS 2 is a promising candidate gene involved in chlorthalidone and Hydrochlorothiazide (HCTZ)‐induced glucose change. This may provide insights into the mechanisms involved in thiazide‐induced hyperglycemia that may ultimately facilitate personalized approaches to antihypertensive selection for hypertension treatment. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifiers: NCT 00246519 and NCT 01203852.
Looking Back, Looking Forward: The Ethical Framing of Complementary and Alternative Medicine in Oncology Over the Last 20 Years
Kimball, Brittany , Geller, Gail , Warsame, Rahma , Kumbamu, Ashok , Jatoi, Aminah , Koenig, Barbara A. , Tilburt, Jon C. , Kimball, Brittany C

Mayo Clinic

The Oncologist | March 9, 2018 | Volume: 23 | Issue: 6 | Pages: 639-641

10.1634/theoncologist.2017-0518 | PMID 29523647 Get It

This commentary takes a look back at views on complementary and alternative medicine and reflects on how those views have evolved, advocating for a conversation around complementary and alternative medicine in cancer care that is more nuanced, patient-centered, and respectful to best meet the needs of patients in the coming decades.
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
Salem, Mohamed E. , Puccini, Alberto , Goldberg, Richard M. , Xiu, Joanne , Weinberg, Benjamin A. , Hwang, Jimmy J., Shields, Anthony F. , Lenz, Heinz‐Josef , Grothey, Axel , Raghavan, Derek , Korn, Wolfgang Michael , Marshall, John L , Philip, Philip A.

Mayo Clinic

Molecular Cancer Research | March 9, 2018 | Volume: 16 | Issue: 5 | Pages: 805-812

10.1158/1541-7786.mcr-17-0735 | PMID 29523759 Get It

Abstract The efficacy of immunotherapy varies widely among different gastrointestinal cancers. Response to immune checkpoint inhibitors is shown to correlate with tumor mutation load (TML), mismatch repair deficiency (dMMR) status, and programmed cell death-ligand 1 (PD-L1) expression. Herein, we quantify TML, dMMR, and PD-L1 expression and determine their interrelationship in gastrointestinal cancers. Here, a total of 4,125 tumors from 14 different gastrointestinal cancer sites were studied using validated assays. Next-generation sequencing was performed on genomic DNA isolated from formalin-fixed paraffin-embedded tumor specimens using the NextSeq platform. TML was calculated using only somatic nonsynonymous missense mutations sequenced with a 592-gene panel. Microsatellite instability (MSI) was assessed using direct analysis of altered known MSI loci in the target regions of the sequenced genes. PD-L1 expression was analyzed by IHC. Interestingly, right-sided colon and small-bowel adenocarcinomas had the highest prevalence of TML-high tumors (14.6% and 10.2%, respectively). Pancreatic neuroendocrine tumors and gastrointestinal stromal tumors had the lowest rates of TML-high (1.3% and 0%, respectively). TML-high was strongly associated with MSI-H (P &lt; 0.0001). However, all TML-high anal cancers (8.3%) were microsatellite stable (MSS). Higher PD-L1 expression was more likely to be seen in MSI compared with MSS tumors (20.6% vs. 7.8%, P &lt; 0.0001). Implications: TML-high rate varied widely among gastrointestinal cancers. Although MSI is conceivably the main driver for TML-high, other factors may be involved. Future clinical trials are needed to evaluate whether the integration of TML, MSI, and PD-L1 could better identify potential responders to immunotherapy. Mol Cancer Res; 16(5); 805–12. ©2018 AACR.
Accuracy of detecting enlargement of aneurysms using different MRI modalities and measurement protocols
Nakagawa, Daichi , Nagahama, Yasunori , Policeni, Bruno , Raghavan, Madhavan L. , Dillard, Seth, Schumacher, Anna , Sarathy, Srivats, Wilson, Saul, Allan, Lauren , Woo, Henry H. , Cloft, Harry J. , Torner, James C., Brown, Robert D., Torner, James C. , Dlouhy, Brian J , Huston, John , Wintermark, Max , Hasan, David

Mayo Clinic

Journal of Neurosurgery | March 9, 2018 | Volume: 130 | Issue: 2 | Pages: 559-565

10.3171/2017.9.jns171811 | PMID 29521585 Get It

OBJECTIVEAneurysm growth is considered predictive of future rupture of intracranial aneurysms. However, how accurately neuroradiologists can reliably detect incremental aneurysm growth using clinical MRI is still unknown. The purpose of this study was to assess the agreement rate of detecting aneurysm enlargement employing generally used MRI modalities.METHODSThree silicone flow phantom models, each with 8 aneurysms of various sizes at different sites, were used in this study. The aneurysm models were identical except for an incremental increase in the sizes of the 8 aneurysms, which ranged from 0.4 mm to 2 mm. The phantoms were imaged on 1.5-T and 3-T MRI units with both time-of-flight (TOF) and contrast-enhanced MR angiography. Three independent expert neuroradiologists measured the aneurysms in a blinded manner using different measurement approaches. The individual and agreement detection rates of aneurysm enlargement among the 3 experts were calculated.RESULTSThe mean detection rate of any increase in any aneurysmal dimension was 95.7%. The detection rates of the 3 observers (observers A, B, and C) were 98.0%, 96.6%, and 92.7%, respectively (p = 0.22). The detection rates of each MRI modality were 91.3% using 1.5-T TOF, 97.2% using 1.5-T with Gd, 95.8% using 3.0-T TOF, and 97.2% using 3.0-T with Gd (p = 0.31). On the other hand, the mean detection rate for aneurysm enlargement was 54.8%. Specifically, the detection rates of observers A, B, and C were 49.0%, 46.1%, and 66.7%, respectively (p = 0.009). As the incremental enlargement value increased, the detection rate for aneurysm enlargement increased. The use of 1.5-T Gd improved the detection rate for small incremental enlargement (e.g., 0.4–1 mm) of the aneurysm (p = 0.04). The location of the aneurysm also affected the detection rate for aneurysm enlargement (p < 0.0001).CONCLUSIONSThe detection rate and interobserver agreement were very high for aneurysm enlargement of 0.4–2 mm. The detection rate for at least 1 increase in any aneurysm dimension did not depend on the choice of MRI modality or measurement protocol. Use of Gd improved the accuracy of measurement. Aneurysm location may influence the accuracy of detecting enlargement.
The Impact of Interrupting Nurses on Mental Workload in Emergency Departments
Kim, Jung Hyup , Parameshwara, Nithin, Guo, Wenbin , Pasupathy, Kalyan S.

Mayo Clinic

International Journal of Human–Computer Interaction | March 9, 2018 | Volume: 35 | Issue: 3 | Pages: 206-217

10.1080/10447318.2018.1447421 Get It